Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022

by Anderson, T.C, Dooling, K.L, Guo, A., Kotton, C.N, Lee, G.M, Leidner, A.J, Masters, N.B, Shepersky, L.
Published 2022